Clinical data show that VEGF contributes to the pathogenesis of both NPDR and PDR.[48,49] According to the results of retrospective studies, anti-VEGF treatment can improve the DRSS and reduce the rate of PDR development.[50]. The gene discussed is VEGFA; the disease is non-proliferative diabetic retinopathy.